Generics BulletinAurobindo Pharma Ltd expects its Europe presence to offset some of the impact from unforeseen US uncertainties like tariffs and predictable ones like price erosion in generic (g) Revlimid (lenalidomid
Generics BulletinAurobindo and MSN Labs are facing a wait of more than a decade to launch their proposed generic versions of Acadia Pharmaceuticals’ Nuplazid (pimavanserin tartrate) 34mg capsules after a US federal di
Generics BulletinAurobindo has notched up yet another European biosimilar approval in a relatively short period, this time receiving a nod from the UK’s Medicines and Healthcare products Regulatory Agency for its Zefy
Generics BulletinFour biosimilars sponsors – Biocon Biologics, Gedeon Richter, Mabxience and Zentiva – have each received dual positive opinions from the European Medicines Agency’s Committee for Medicinal Products fo